BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9509064)

  • 1. Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness.
    Shimon I; Hinton DR; Weiss MH; Melmed S
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):23-9. PubMed ID: 9509064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-binding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription.
    Shimon I; Hüttner A; Said J; Spirina OM; Melmed S
    J Clin Invest; 1996 Jan; 97(1):187-95. PubMed ID: 8550832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland.
    Turner HE; Nagy Z; Sullivan N; Esiri MM; Wass JA
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):337-44. PubMed ID: 10971451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6, a growth promoting cytokine, is present in human pituitary adenomas: an immunocytochemical study.
    Tsagarakis S; Kontogeorgos G; Giannou P; Thalassinos N; Woolley J; Besser GM; Grossman A
    Clin Endocrinol (Oxf); 1992 Aug; 37(2):163-7. PubMed ID: 1327588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
    Ma W; Ikeda H; Yoshimoto T
    Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas.
    Komatsubara K; Tahara S; Umeoka K; Sanno N; Teramoto A; Osamura RY
    Endocr Pathol; 2001; 12(2):181-8. PubMed ID: 11579684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The release of leptin and its effect on hormone release from human pituitary adenomas.
    Korbonits M; Chitnis MM; Gueorguiev M; Norman D; Rosenfelder N; Suliman M; Jones TH; Noonan K; Fabbri A; Besser GM; Burrin JM; Grossman AB
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):781-9. PubMed ID: 11422113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
    Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
    Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.
    Fazekas I; Bácsy E; Varga I; Slowik F; Bálint K; Pásztor E; Czirják S; Gláz E
    Folia Histochem Cytobiol; 2000; 38(3):119-27. PubMed ID: 10970071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
    Kristof RA; Schramm J; Redel L; Neuloh G; Wichers M; Klingmüller D
    Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining Cadherin Expression with Molecular Markers Discriminates Invasiveness in Growth Hormone and Prolactin Pituitary Adenomas.
    Chauvet N; Romanò N; Meunier AC; Galibert E; Fontanaud P; Mathieu MN; Osterstock G; Osterstock P; Baccino E; Rigau V; Loiseau H; Bouillot-Eimer S; Barlier A; Mollard P; Coutry N
    J Neuroendocrinol; 2016 Feb; 28(2):12352. PubMed ID: 26686489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocorticotropic hormone secreting pituitary adenomas: analysis of growth fraction using the MIB-1 antibody.
    Mastronardi L; Guiducci A; Spera C; Puzzilli F; Liberati F; Ruggeri A; Peciarolo A
    Tumori; 2000; 86(3):229-32. PubMed ID: 10939604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue kallikrein is associated with prolactin-secreting cells within human growth hormone-secreting adenomas.
    Jones TH; Figueroa CD; Smith CM; Cullen DR; Bhoola KD
    J Endocrinol; 1992 Jul; 134(1):149-54. PubMed ID: 1500840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relationship between cell proliferation activity and secretory activity in pituitary adenoma--a review of 63 cases].
    Asano K; Kubo O; Tajika Y; Huang MC; Takakura K
    No To Shinkei; 1996 Jun; 48(6):543-9. PubMed ID: 8703557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome.
    Turner HE; Nagy Z; Gatter KC; Esiri MM; Harris AL; Wass JA
    J Endocrinol; 2000 May; 165(2):475-81. PubMed ID: 10810311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapy.
    Colao A; Ferone D; Lombardi G; Lastoria S
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):713-21. PubMed ID: 12072040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of prothymosin alpha is related to pituitary adenoma recurrence but not to adenoma invasiveness and proliferation.
    Pawlikowski M; Radek M; Kunert-Radek J; Jaranowska M; Świętosławski J; Winczyk K
    Endokrynol Pol; 2014; 65(5):382-6. PubMed ID: 25301489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA synthesis by pituitary tumours, with reference to plasma hormone levels and to effects of bromocriptine.
    Lloyd HM; Jacobi JM; Willgoss DA
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):79-85. PubMed ID: 7641414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.